Companies Dominating the Non-Coding RNA Assays Landscape
- Thermo Fisher Scientific Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Springer Nature Limited
- Applied Microarrays Inc.
- C D Genomics
- RELX Group
- MilliporeSigma
- QIAGEN
- Agilent Technologies, Inc.
- Danaher Corporation
- Eppendorf SE
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of non-coding RNA assays is evaluated at USD 382.84 million.
The non-coding RNA assays market size was over USD 307.83 million in 2024 and is poised to exceed USD 1.76 billion by 2037, growing at over 14.4% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of chronic diseases, and rising geriatric population will boost the market growth.
North America industry is poised to account for largest revenue share of 40% by 2037, attributed to availability of a large number of biotechnology and pharmaceutical companies.
The major players in the market are Thermo Fisher Scientific Company, Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE
